Currently Accepting Nominations
This page serves as the designated site that is used to solicit nominations for technical expert panel members for CMS measure development and maintenance contractors. Individuals with expertise in the relevant fields including clinicians, statisticians, quality improvement, methodologists, and pertinent measure developers, as well as consumers, are encouraged to submit nominations. Person and family membership on TEPs is a very important part of the measure development process. TEP members are chosen to provide input to the measure contractor based on their personal experience and training. It is critical to the success that TEP members represent a diversity of perspectives and backgrounds.
TEPs Accepting Nominations:
- Behavioral Health Measures: Development, Reevaluation, & Maintenance
- MACRA Episode-Based Cost Measures – Clinical Subcommittee
- Hospital Quality Star Ratings on Hospital Compare
The TEP nomination period opens on June 14, 2019 and closes on August 2, 2019. Submit all nomination materials by the closing date.
The Centers for Medicare & Medicaid Services (CMS) engaged Mathematica and its partners to develop, re-evaluate, and maintain behavioral health measures that are used in the Inpatient Psychiatric Facility Quality Reporting (IPFQR) program and in several other CMS reporting and payment programs (the Quality Payment Program, Post-Acute Care Quality Initiatives, the Hospital Inpatient Reporting Program, the Marketplace Quality Rating System, and the Center for Medicare and Medicaid Innovation). The contract name is Behavioral Health Measures: Development, Reevaluation, & Maintenance (BHM-DRM). The contract number is 75FCMC18D0032. Mathematica plans on convening a group of stakeholders and experts to help guide the maintenance and development of measures for these programs.
The goal of this project is to provide information, support, feedback, and perspective on the identification, development, specification, testing, prioritization, maintenance, re-evaluation, and implementation of behavioral health quality measures for CMS’s quality-reporting programs. These measures are intended to support CMS’s and the Quality Improvement Organization Program’s missions and to fulfill the requirements of the IMPACT Act.
The objective of the BHM-DRM TEP is to provide feedback and perspective on the identification, development, specification, testing, maintenance, re-evaluation, and implementation of measures for the IPFQR program and other CMS behavioral health programs.
As part of its measure development and maintenance process, Mathematica requests input from a broad group of stakeholders, which may include policymakers, providers (psychiatrists, psychiatric nurses, clinical social workers, psychologists, addiction specialists, and others with experience in inpatient psychiatric facilities and behavioral health settings), quality measure experts, methodologists, patients and their caregivers, and patients’ representatives or advocates. A well-balanced representation of stakeholders on the TEP will help ensure that key perspectives are considered during measure selection, development, and maintenance.
Scope of responsibilities
The TEP will advise Mathematica and its partners (the project team) on the identification and development of clinical quality measures in terms of their importance, scientific acceptability, feasibility, and usability. Additional TEP input may be requested for existing measures. The TEP’s specific duties include the following:
- Reviewing proposed measure concepts based on findings from the environmental scan and gap analysis conducted by the project team
- Advising the project team on the prioritization of quality measures
- Evaluating issues related to the importance and implementation of measures identified and developed under this contract
- Providing feedback on the development and specifications of behavioral health measures for implementation in CMS’s quality reporting programs
- Reviewing and providing feedback on existing measures
- Reviewing and providing feedback on TEP Summary Reports
TEP members will be asked to review briefing materials before meetings. They may also be called upon periodically to review information and provide comments between meetings. TEP members will be asked to review briefing materials prior to meetings. Additionally, TEP members may be called upon periodically to review information and provide comments between meetings.
Mathematica and its partners will use the following criteria to identify concepts and assess measures for development and maintenance:
- Relevance and importance to patients and their caregivers
- Program appropriateness
- Evidence of importance
- Feasibility, usability, and scientific acceptability of measures
- Existence of competing measures
- CMS and federal measurement priorities
The TEP will provide input throughout the measure development and maintenance process. The project team will consider the TEP’s recommendations and convey them to CMS. The team will complete Summary Reports of TEP proceedings after meetings to highlight discussions and to document recommendations; these Summary reports will be publicly posted. The TEP will make decisions by voting or by consensus, depending on the topic.
The project team will ensure confidentiality in TEP reports by summarizing the discussion topics and removing the names of TEP members who make comments during meetings.
Estimated number and frequency of meetings
TEP members will meet up to four times per 12-month period, with one meeting per year in person and the rest via teleconference. This project is expected to span five 12-month periods.
Details regarding this TEP are posted in the Downloads section below
The nomination period for four Clinical Subcommittees opens in March and closes on April 12, 2019, at 11:59 pm EST. Please submit all nomination materials before the closing date.
We will, however, continue to accept nominations on a continual basis after this date; nominees who submit their information after this date will enter a standing pool of nominees who may be selected for participation in condition- or procedure-specific workgroups that will be convened within each Subcommittee.
The Centers for Medicare & Medicaid Services (CMS) has contracted with Acumen, LLC to develop care episode and patient condition groups for use in cost measures to meet the requirements of the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA). The contract name is “MACRA Episode Groups and Cost Measures.” The contract number is HHSM-500-2013-13002I, Task Order HHSM-500-T00002. As part of the development and maintenance processes, Acumen, LLC convenes groups of stakeholders and experts who contribute direction and thoughtful input during development of episode-based cost measures.
The project’s overall objective is to develop episode-based cost measures suitable for potential use in the Quality Payment Program. For more details about the project background, including development activities undertaken in previous years, please see this summary on the MACRA Feedback Page.
Acumen’s measure development approach is to convene clinician expert panels called Clinical Subcommittees (CS) focused on particular clinical areas in cycles of development (“waves”). In Wave 3 beginning in 2019, Acumen is convening the following:
- Three CS to develop procedural and acute inpatient medical condition episode based cost measures in the following clinical areas: Dermatologic Disease Management; General and Colorectal Surgery; and Hospital Medicine.
- A new Chronic Condition and Disease Management CS to develop episode-based cost measures for chronic conditions. This is the first opportunity to contribute to the development of episode-based chronic condition cost measures for potential use in the Quality Payment Program.
All members who submit their nomination materials by the deadline and who are accepted to a Clinical Subcommittee will attend the first meeting.
- The Clinical Subcommittee is a large body of clinicians that will meet during the last week of May 2019. Members of the Chronic CS and Dermatologic CS will meet in-person in Washington, D.C., while members of the other CS will meet via an online webinar. (Exact dates for each Subcommittee are available on the nomination form.)
- The purpose of the initial CS meetings is to: (i) select which episode-based cost measure to develop, (ii) discuss the measure intent, and (iii) provide input on the desired composition of the workgroup that will build out the selected measure.
- In addition to these topics, the Chronic CS will also consider and provide input on the basic framework of chronic condition episode groups, including logic for opening (or “triggering”) an episode and attributing episodes to clinicians.
After these initial meetings, we will then create smaller measure-specific workgroups within each Clinical Subcommittee based on input from the Clinical Subcommittee about which episode-based cost measure(s) to develop and the recommended composition of the workgroups.
- The workgroups will include approximately 15 members whose specialty, expertise, or experience is aligned with the focus of the selected episode-based cost measure and the workgroup composition criteria discussed by the Subcommittee during the first meeting.
- The workgroups will be composed from within the membership of the Clinical Subcommittee, as well as the standing pool of nominees where necessary.
- Workgroup members will attend an in-person meeting in Washington DC in August 2019 (exact dates to be determined) and provide detailed input on each component of the episode-based cost measure.
List of Subcommittees Participating in Wave 3:
The list below presents the list of Subcommittees that we are recruiting for through this Call for Nominations. Below each Subcommittee, we list the episode groups in that Subcommittee’s clinical area that have been previously recommended for development by clinician stakeholders. However, this list is not limiting; Subcommittees may recommend additional episode groups.
- Chronic Condition and Disease Management
- Chronic Kidney Disease
- Chronic Liver Disease
- Chronic Obstructive Pulmonary Disease
- Heart Failure
- Inflammatory Bowel Disease
- Osteoarthritis of the Knee
- Peripheral Artery Disease
- Dermatologic Disease Management
- Basal or Squamous Cell Carcinoma
- Melanoma Resection
- Mohs Surgery
- General and Colorectal Surgery
- Cholecystectomy/Surgical Procedure for Gall Bladder Disease
- Colon Resection
- Hernia Repair (Incisional or Ventral)
- Hospital Medicine
- Deep Vein Thrombosis
- Kidney and Urinary Tract Infections
- Pulmonary Edema
- Renal Failure Not Requiring Dialysis
All Subcommittee and/or Workgroup members who participated in Wave 2 in 2018 and are interested in continuing with Wave 3 of cost measure development must indicate their interest in an abbreviated nomination form shared directly with members via email. Existing members do not need to submit their nomination via the public nomination form. Please contact the Acumen measure development team if you did not receive an email.
Subcommittee members who participated in Wave 1 but not Wave 2 should fill out the public nomination form to ensure we have the most recent information.
Future Clinical Subcommittees
If you would like to be a part of a Clinical Subcommittee, but do not practice in any of the clinical areas we are recruiting for above, there may be future waves in which we convene additional Clinical Subcommittees. If you are interested in receiving updates regarding any of these future Subcommittees, please provide your contact information on the MACRA Clinical Subcommittee Mailing List form.
List of Clinicians we are Recruiting
We are recruiting physicians, physician assistants, nurse practitioners, clinical nurse specialists, certified registered nurse anesthetists, physical therapists, occupational therapists, speech-language pathologists, audiologists, nurse midwives, clinical social workers, clinical psychologists, dietitians, nutritional professionals, and other clinicians with experience in the clinical areas listed above.
If you are not one of the clinician types listed above but believe your input would be valuable for the Wave 3 Subcommittees, we encourage you to apply.
Desired Qualifications of Clinical Subcommittee Members:
- Medical credentials relevant to the types of clinicians listed above
- Familiarity with medical coding (ICD-10, CPT/HCPCS, DRG)
- Board-certified or other professional certifications, as applicable
- Experience treating Medicare patients
Expected Time Commitment:
Tasks for All Clinical Subcommittee Members
- Review preparatory materials shared ahead of the meeting and complete pre-meeting survey
- Chronic CS and Dermatologic CS: Attend 1 day-long meeting for each CS in the last week of May 2019
- All Other CS: Attend 1 webinar for each CS in May 2019 (exact dates for each Subcommittee are available on the nomination form)
Tasks for Workgroup Members Only
- Review preparatory materials shared ahead of the meeting and complete pre-meeting survey
- Attend 1 day-long in-person meeting for workgroup members only for episode group specification in Washington, D.C. in August 2019 (exact dates will be determined taking into consideration workgroup member availability)
Nominees are required to submit a completed MACRA Clinical Subcommittee Nomination Form. As part of this form, nominees are required to upload (i) a letter of interest (not to exceed two pages) highlighting experience/knowledge relevant to the expertise described above and involvement in measure development, and (ii) a current curriculum vitae or summary of relevant experience. If you wish to nominate yourself or other individuals for consideration, please complete the form by April 12, 2019, at 11:59 pm EST.
If you would like to receive additional information on the CS nomination and measure development processes, or if you have any questions about the Clinical Subcommittees, the nomination process, or this project generally, please email firstname.lastname@example.org.
A PDF copy of the draft charter for the Wave 3 Clinical Subcommittees is included in the Downloads section at the bottom of this webpage. If you would like to receive a 508-compliant PDF version of the nomination form for submission via email instead of the web-based form linked above, please email email@example.com to receive a blank form.
The TEP nomination period opens on July 18, 2019 and closes on August 19, 2019. Please submit all nomination materials by the closing date.
The Centers for Medicare & Medicaid Services (CMS) has contracted with Yale New Haven Health Services Corporation – Center for Outcomes Research and Evaluation (CORE) and Lantana, Inc. for the development, maintenance, and reevaluation of the publicly reported Overall Hospital Quality Star Ratings. The CORE contract name is Development, Reevaluation, and Implementation of Outcome/Efficiency Measures for Hospital and Eligible Clinicians, Base Year; contract number HHSM-75FCMC18D0042, Task Order Number HHSM-75FCMC19F0001, and the Lantana contract is called MIDS III Hospital Compare Support Contract (HCSC); contract number HHSM-500-2013-13010I/HHSM-500-T0001. As part of its measure development process, project contractors are convening groups of stakeholders and experts who contribute direction and thoughtful input during project development and maintenance.
The primary goal of this TEP is to support the evolution of the Overall Hospital Quality Star Ratings methodology. This approach is consistent with CMS’ approach for iterative improvement of quality measures and quality programs. The Star Rating project is designed to create a summary of current measures publicly reported on Hospital Compare so that these aspects of quality are presented in a meaningful and accessible way to patients and consumers. The TEP is encouraged to provide input on any or all considerations of Star Ratings as part of its deliberations. TEP recommendations and discussion will inform the refinement of the methodology.
We are seeking a TEP of approximately 15-20 individuals with differing perspectives and areas of expertise, such as:
Subject matter expertise:
- Hospital quality topic knowledge
- Statistical modeling and expertise
- Other topic knowledge (measure development, consumer testing, star ratings systems)
- Consumer/patient/family (caregiver) perspective
- Healthcare disparities
- Performance measurement
- Quality improvement
- Purchaser perspective
Potential TEP members must be aware that participation on the TEP is voluntary. As such, individuals wishing to participate on the TEP should understand that their input will be recorded in the meeting minutes. Proceedings of the TEP will be summarized in a report that is disclosed to the general public. If a participant has disclosed private, personal data by his or her own choice, then that material and those communications are not deemed to be covered by patient-provider confidentiality. If patient perspective participants (only), including consumers, patient advocates, and family caregivers, wish to keep their names confidential, that request can be accommodated. Any questions about confidentiality will be answered by CORE/HCSC.
All potential TEP members must disclose any current and past activities that may pose a potential conflict of interest for performing the tasks required of the TEP. All potential TEP members should be able to commit to the anticipated time frame needed to perform the functions of the TEP.
Nominees not chosen for the TEP may be asked to join one of the Overall Star Rating work groups, which have similar scope of topics and member responsibilities but focus on the provider or patient perspectives, rather than technical input.
CORE/HCSC is seeking patients and patient perspectives, such as consumers, patient advocates, and caregivers, to participate on a TEP. We are seeking patients that have ever been hospitalized, caregivers that have ever sought care for others, and advocates that represent patients to join the TEP. Patients that have been hospitalized and caregivers that have sought care for others can provide unique and essential input on quality measures and accessing hospital care based on their own experiences and perspectives. Patient perspective nominees should submit a completed and signed TEP Nomination Form and letter of interest as described below but are not required to submit a curriculum vitae.
TEP Expected Time Commitment:
CORE/HCSC anticipates holding at least one meeting (in-person or teleconference) between September 2019 and March 2020. In person meetings are generally a full business day and usually held in the Baltimore-Washington DC area. Teleconference meetings usually last between one and a half to two hours. As development and refinement work may occur after March 2020, TEP members may be asked to reconvene and participate in follow-up teleconference meetings after March 2020 to provide feedback for the Star Rating methodology.
In addition, the TEP members will review materials provided in advance of meetings and complete any online surveys.
A completed and signed TEP Nomination form located in the download section below.
The nomination form includes a consent and confidentiality statement.
A letter of interest (not to exceed two pages) highlighting experience/knowledge relevant to the expertise described above and involvement in measure development. Consumer/patient/family (caregiver) applicants/nominees are not expected to have experience in measure development.
Curriculum vitae or a summary of relevant experience for a maximum of 10 pages. Consumer/patient/family (caregiver) applicants/nominees are not required to submit a curriculum vitae.
The Nomination forms and proposed TEP Charter are found in the download section below.
If you wish to nominate yourself or other individuals for consideration, please complete the form and email it to: firstname.lastname@example.org.
- Behavioral Health Measures: Development, Reevaluation, & Maintenance [ZIP]
- MACRA Episode-Based Cost Measures – Clinical Subcommittee – Charter [PDF]
- Hospital Quality Star Ratings on Hospital Compare [ZIP]
- Page last Modified: 07/23/2019 7:43 AM
- Help with File Formats and Plug-Ins